Management of Obesity – NHS endorsed initiatives, therapies and pharmacotherapies

This is a Novo Nordisk Sponsored meeting

Novo Nordisk has provided sponsorship to the Association of British Clinical Diabetologists (ABCD) to fully fund all costs for the development and delivery of this webinar, including creation, administration, promotion and speaker honoraria. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ABCD.

Management of Obesity –NHS endorsed initiatives, therapies and pharmacotherapies
Tuesday 8th November 2022, 19.00 - 20.00

In the first of this webinar series focussing on obesity, join Dr Hazlehurst and an expert panel to discuss the management of obesity focusing on NHS endorsed initiatives, therapies and pharmacotherapies.

Discussions will cover;

Understanding of current and projected obesity pharmacotherapy within the UK
Understanding the impact of pharmacotherapy on patient outcomes and service use
Understand the impact of pharmacotherapy on the delivery of UK obesity services and the anticipated effect in the coming years

Please join us for the live Q & A during this session.

This webinar is for UK Healthcare professionals only

Speakers

Sally Abbott

Sally Abbott works both as an academic and as a clinical dietitian, specialising in obesity management. Sally is the Clinical Lead Dietitian for Tier 3 & Tier 4 services at University Hospitals Coventry & Warwickshire NHS Trust and Assistant Professor in Dietetics at Coventry University. She was the European winner of the IFSO (International Federation for the Surgery of Obesity) Integrated Health Scholarship in 2018 for her commitment to bariatric surgery dietetics and sits on national committees, including on the British Obesity and Metabolic Surgery Society (BOMSS) council and acting Bariatric Officer for the British Dietetic Association (BDA) Obesity Specialist Group. She is an EASO (European Association for Study of Obesity) National Clinical Fellow in recognition of her clinical expertise in the field.
Dr. Jonathan Hazlehurst

Coming soon ..
Professor Barbara McGowan

Professor Barbara McGowan is a Consultant Endocrinologist at Guy's and St Thomas' Hospital (GSTT) and Professor in Diabetes and Endocrinology at King’s College London. She was awarded a PhD from Imperial College London for investigating ‘The role of relaxin-3 on energy homeostasis and the hypothalamic-pituitary-axis’ and the role of gut hormones and other neuropeptides in appetite control.
She is R&D lead for Diabetes and Endocrinology at GSTT and the South London Specialty lead for the Metabolic and Endocrine research network. She leads the obesity bariatric service at GSTT where she manages patients with severe and complex obesity. Her areas of research interest are in gut hormones and appetite control, pharmacotherapy for obesity and remission of type 2 diabetes post-bariatric surgery. She is an investigator for several obesity clinical trials and was awarded an NIHR/RCP/CRN prize in recognition of outstanding research within the NHS.
Professor McGowan is a SCOPE National fellow, a member of the European Society for Endocrinology Policy and Advocacy Task Force and a member of the RCP Advisory Group on Weight and Health. She chairs the GIRFT/ABCD Obesity Task Force. She has served as Treasurer of the Society for Endocrinology and as a Trustee of the Association for the Study of Obesity.
Professor ALEX MIRAS

Alex Miras is Professor of Endocrinology at Ulster University. His clinical and research work focus solely on Obesity and type 2 diabetes. He has contributed to the clinical management and research in Obesity over the last 14 years, through his work at a high throughput Obesity Centre. The specialist interests of his research Group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices and obesity surgery.
Professor John Wilding

Professor John Wilding leads clinical research into Obesity, Diabetes and Endocrinology at the University of Liverpool, where he has worked since 1996, after training in Southampton and London. His clinical interests focus on caring for people with diabetes and obesity and he leads specialist services for obesity at Aintree University Hospital – designated a Centre for Obesity Management by the European Association for the Study of Obesity.
John’s research team focusses on developing and evaluating treatments for obesity and diabetes. He has published over 350 papers, chapters and review articles, including clinical trials in diabetes and obesity, studies of adipocyte biology and metabolism.
He chairs the National Clinical Research Network Metabolic and Endocrine Speciality Group.
He is a past Chair of the UK Association for the Study of Obesity, a member of the Royal College of Physicians Advisory Group on Nutrition, Weight and Health and past President of the World Obesity Federation.

Management of Obesity – NHS endorsed initiatives, therapies and pharmacotherapies

Gold

Silver

Gold

Silver

Management of Obesity – NHS endorsed initiatives, therapies and pharmacotherapies

Sally Abbott

Dr. Jonathan Hazlehurst

Professor Barbara McGowan

Professor ALEX MIRAS

Professor John Wilding

Search the Association of British Clinical Diabetologists